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Introduction
Parkinson's disease (PD) is a progressive neurodegenerative disease affecting the human nervous system on a multisystem level. The motor symptoms are considered to derive from a loss of dopaminergic projection neurons in the substantia nigra (SN) and accumulation of iron deposits in the SN. DBS is nowadays a well established therapy not only for advanced PD with fluctuating motor symptoms and dyskinesia [1] , but has been proven to be superior to medical therapy at early stages of PD ahead of disabling motor complications [2] . In younger patients the subthalamic nucleus (STN) is the target of choice to improve motor symptoms. Most often STN is targeted bilaterally [3] . The globus pallidus internus (GP) is another effective target for treatment of the levodopa-responsive symptoms and motor fluctuations [4, 5, 6, 7, 8] . Unilateral versus bilateral approaches to DBS both emerged to be efficacious to improve motor dysfunction [9] , yet it remains an open question as how to appropriately determine unilateral approaches for a subset of patients. Patients with marked asymmetry of motor symptoms may benefit from unilateral DBS, if the target nucleus can be properly identified.
The rationale for MRI in PD is traditionally anchored in the exclusion of atypical Parkinson syndromes.
Current diagnostic methods for Parkinsonism include in some extent 18F-fluorodeoxyglucose
Positron Emission Tomography (FDG-PET) as well as dopaminergic receptor imaging by PET or single photon emission CT (SPECT). 18F-fluorodopa PET, 11C-dihydrotetrabenazine PET, FDG-PET and 123I-beta-carbomethoxy-3beta-(4-iodophenyl)tropane (DAT)-SPECT have been used to detect the loss of dopaminergic presynaptic terminals in the putamen originating from the SN pars compacta in PD patients [10] . Neuromelanin imaging at 3T MRI offers another aspect of changes within PD [11, 12] . Furthermore transcranial ultrasonographic imaging of the midbrain is discussed as a possible method for early assessment of degeneration of SN. [13, 14] .
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Methods to assist diagnosis of PD with MRI are now evolving, encompassing quantitative iron assessment and neuromelanin sensitive MRI [15, 16] . In research setting, arterial spin labeling and functional MRI using connectivity analysis have found profound differences between PD and HC [17, 18] . To our knowledge, no previous MRI study aimed at a prediction of DBS outcome, except of a seminal study [19] that correlated T2r in STN to neurophysiological parameters, disease duration and laterality.
The degeneration of SN in PD involves iron accumulation, which can be assessed by T2 and T2* relaxometry. These values, correlated with micro structural characteristics of tissues, provide absolute, tissue specific, field strength and machine independent T2 values and are highly sensitive to e.g. iron content [20] . In this study, we investigated whether a decrease of T2 relaxation times in the subthalamic nucleus (STN) can be used as surrogate marker for target selection in DBS. Our assumption was that i) an asymmetric clinical presentation is reflected by asymmetric degeneration within the basal ganglia loops, which could possibly be detected by
T2r changes compared to HC and that ii) an asymmetric degeneration may affect the motor outcome of DBS. Patients with a high asymmetric index in motor function have profited of unilateral DBS in means of improvement of ipsi-and contralateral UPDRS, so that only few patients required a second DBS [21] . The T2r values could predict the degree of degeneration requiring bilateral or only unilateral DBS. Furthermore a severe degeneration within the basal ganglia loop, as seen by T2r values could predict a poor response to DBS and affect future patient eligibility.
The neuroradiological assumption is to see, if the iron content as seen by T2r values asymmetrically or symmetrically correlates with PD symptoms and/or DBS outcome.
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Subjects and Methods
Fourteen DBS patients (9 men, 5 women) with the standard neurological preoperative work-up of determining levodopa-responsive PD with motor complications and without contraindications underwent preoperative imaging including T2 relaxometry. Inclusion criteria to this study were DBS implantation, completed imaging protocol and pre-and post-operative UPDRS assessment.
Two male subjects had to be excluded because of motion artifacts in the imaging. The UPDRS scores I, II and III were assessed by a specialized paramedic of the Movement Disorder Center of our Institution`s Neurological Department. UPDRS I ("cognitive") was determined during "on"-state while UPDRS II ("daily living") and UPDRS III ("motor") were determined in "on" as well as in "off" state. In addition the UPDRS III scores were determined separately for left and right sided symptoms yielding the according left and right UPDRS III subscores.
All scores were determined 3 to 6 weeks preoperatively as well as 12 to 26 weeks postoperatively. DBS outcome was assessed by analyzing the differences of respective preoperative and postoperative UPDRS scores.
Patients and controls were examined at the 3 Tesla scanners (Siemens Magnetom Trio and Siemens Magnetom Verio; Siemens Medical Solutions, Erlangen, Germany) of our institution.
T2r MRI data were acquired with identical multi-contrast spin echo (SE) sequences on both of the similar scanners. The multi-echo, fast spin echo sequence used the following parameters: 28 
The fitting algorithm for each ROI was applied to the 7 measurements from TE = 24 ms to TE = 96 ms. Measurements at TE = 12 ms were omitted to avoid non-exponential components of the signal at very short TE [24] . Furthermore the formula assumes the constant including the factor
(1 − exp (− 1 )) being independent from TE. According to the 7 ROIs the calculations resulted in a set of 7 T2 values for every patient and control. As the tissue specific T2r values are
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calculated from the decay curves regardless of absolute signal intensities the measurements are independent of the actual 3T scanner used.
For statistical workup, the measured T2r values for left side and right side were supplemented by the T2r mean, max and min values as well as the difference between left and right T2r values (all values in ms). Also the UPDRS scores were supplemented in a similar manner by difference scores (difference pre-operative minus post-operative, difference "on"-state minus "off"-state).
Pearson correlations of the resulting sets of T2r values and UPDRS scores were determined and analyzed for patients and HC. Furthermore for patients and HC possible correlations of T2r values with sex or age were tested.
Results:
UPDRS pre-and post-operative: Patients averaged preoperative and postoperative total UPDRS I, II and III scores in "off"-state and in "on"-state are shown in Table 1 . The designation "on" and "off" refers to dopaminergic medication. The DBS itself, after implantation, was always switched on. 
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Furthermore, the data showed a significant correlation of the difference in preoperative UPDRS III scores in "off" vs. 
Discussion
This study aimed to investigate whether decreases in the T2r in the STN and SN are predictive for motor outcome in PD. Two points stand out from our study:
1) T2r changes in the SN and in STN differentiate PD patients from HC. This finding confirms previous studies [25, 26] and has been confirmed by transcranial sonography [27] . Several MRI methods are on trial for initial diagnosing PD [15] . T2r is not the only MRI marker for distinction of PD and HC, e.g. resting state functional MRI, R2*, mean diffusivity and fractional anisotropy have also been found to have significant differences within the basal ganglia [28, 29, 30] . Our findings implicate, that T2-relaxometry of STN and SN should be further evaluated to test if it offers the potential to differentiate early PD from HC and secondary Parkinson syndromes. While patients tend to show an unilateral decrease of STN T2r the laterality of symptoms was not reflected by the asymmetry of STN T2r. Lateralized manifestations of motor symptoms are characteristic for idiopathic PD [32] which, however, is invariably a bilateral disorder. During the progression of the disease laterality is usually preserved to some degree. This has until date
2) STN asymmetry and
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not been correlated to intrinsic unilateral or side dominant changes within the brain on MRI. The dopaminergic innervation of the striatum is known to reflect the asymmetry of symptoms during onset and progression of PD [33] . However, there is evidence to suggest that components of the basal ganglia loops are functionally connected across hemispheres [34] . This supports the observation that DBS outcome was best when at least one STN had near to normal T2r, independent of the most affected side of symptoms. Though, in context of DBS with targeting the basal ganglia, the degree of affection and laterality may impact clinical outcome [35] .
Patients may also profit more of DBS during an earlier stage [36, 37] . [38] . These findings may reflect different subgroups of PD, corresponding to the variation in motor symptoms exhibited in the disorder [39, 25] . Increasing iron content in the SN in progression of PD has been described [40] . The overall iron content in the STN did not seem to affect the outcome as neurodegeneration typically affects the SN but not the STN. Interestingly, T2r in the STN as a structural parameter nevertheless seems to correlate with clinical findings.
While the mean values of STN T2r left and right provided no additional value, the minimum values of were correlated to DBS outcome with respect to UPDRS III. Very low minimum STN T2r predicted negative DBS outcome. More detailed, patients and controls differed in terms of decreased STN T2r(< 58 ms) either uni-or bilaterally. The clinical data confirmed the UPDRS improvement in all but three patients, in whom levodopa-resistant axial signs worsened after neurosurgery, as has been reported in earlier studies [4] . Alternative Targets have also been considered, mainly GPi, with no relevant differences in results of UPDRS improvement [5] . The M A N U S C R I P T
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latter may offer an alternative target, if the STN T2 values are very low and considered predictive for a negative outcome.
The effect of a left dominant hemisphere on DBS has been considered [9] . The DBS performed on the dominant side was not proven to have a more beneficial effect than the non-dominant side.
Our observations on the T2 values of SN are congruent with literature [41] . Noteworthy is the correlation of SN minimum T2r values to the levodopa motor response (UPDRS III "off" vs.
"on"). This has not been described before and should be investigated further.
A limitation of this study is the small number of patients affecting the power to detect differences. However, the correlations we report are highly significant. Our controls were recruited from a distinctly younger age group, which may result in a bias, even if no correlations with age were found. A study with age matched HC [42] found less pronounced T2r differences between patients and HC.
Though the initial assumption that the asymmetric iron content could correlate with asymmetric clinical disease could not be proved, the data suggest that the outcome of DBS may correlate to the maximum iron content in either of the STN. Further evaluation is needed to ensure which patients possibly have to be excluded from DBS.
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Conclusion
The minimum T2r values of the left or right STN may be a predictive factor for motor improvement after STN-DBS. 
